Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-11-25

FDA Approved: VARITHENA — Original Application (Biocompatibles, Inc.)

View source ↗

Summary

FDA approved Varithena (polidocanol) as an original application for the treatment of varicose veins of the leg due to incompetent great saphenous vein reflux.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varithena (polidocanol injectable foam)

Snippet

ORIG AP for VARITHENA (POLIDOCANOL)